Literature DB >> 10598964

Early recurrence of atrial fibrillation after external cardioversion.

W C Yu1, Y K Lin, C T Tai, C F Tsai, M H Hsieh, C C Chen, T L Hsu, Y A Ding, M S Chang, S A Chen.   

Abstract

UNLABELLED: Early recurrence of atrial fibrillation (AF) has been reported to occur in a significant number of patients after internal cardioversion. However, information about early recurrence of AF after external cardioversion has never been reported. The present study was conducted to investigate the clinical and electrophysiological characteristics of early recurrence of AF and its role in failure of cardioversion in patients with chronic AF. METHODS AND
RESULTS: The study included 50 consecutive patients, age 69+/-9, with a history of chronic AF for more than 3 months duration and electrical cardioversion. They were divided into two groups according to the presence (group 1) or absence (group 2) of early recurrence of AF. There were 13 (26%) patients in group 1 and 37 (74%) patients in group 2. The age, gender, duration of AF, left ventricular function, left atrial dimension, and underlying heart disease were similar between group 1 and 2. Forty-five patients were successfully converted to sinus rhythm with a mean energy of 158+/-57 . Among those who failed to be converted to sinus rhythm, 4 (80%) belonged to group 1 and 1 (20%) belonged to group 2. The early recurrences of AF were initiated with consecutive APDs; but the numbers of APD in the first 30 seconds after cardioversion were similar between group 1 and 2. However, the coupling interval of the second APD was shorter in group 1 than group 2 (188+/-22 vs 324+/-59 ms, P = 0.003). Nine of the 13 early recurrences were prevented by an increase of shock energy (n = 3) or intravenous amiodarone infusion (n = 6). There were no differences in duration of follow-up, recurrence rate, and time interval to recurrence between group 1 and group 2. Early recurrence of AF occurred in 26% of chronic AF patients who underwent external electrical cardioversion and was a major cause of failure in cardioversion. Early recurrence of AF was initiated by APDs with decreasing coupling intervals and could be prevented with an increase of shock energy or amiodarone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598964     DOI: 10.1111/j.1540-8159.1999.tb00380.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Atria are more susceptible to electroporation than ventricles: implications for atrial stunning, shock-induced arrhythmia and defibrillation failure.

Authors:  Vadim V Fedorov; Geran Kostecki; Matt Hemphill; Igor R Efimov
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

2.  Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.

Authors:  B Dijkman; H J Wellens
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

3.  Initial experience with single lead intracardial cardioversion for refractory atrial fibrillation.

Authors:  H A van de Klippe; C P Allaart; J H Ruiter
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

4.  Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias.

Authors:  Kostas Polymeropoulos; Vassilios P Vassilikos; Lilian Mantziari; Stelios Paraskevaidis; Theodoros D Karamitsos; Sotirios Mochlas; Georgios Parcharidis; Georgios Louridas; Ioannis H Styliadis
Journal:  Cardiol Res Pract       Date:  2011-05-24       Impact factor: 1.866

5.  The impact of cardiac rhythm on the mitral valve area and gradient in patients with mitral stenosis.

Authors:  Hasan Arı; Selma Arı; Alper Karakuş; Sencer Camcı; Kübra Doğanay; Ahmet Tütüncü; Mehmet Melek; Tahsin Bozat
Journal:  Anatol J Cardiol       Date:  2017-05-24       Impact factor: 1.596

6.  Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.

Authors:  Andreas Müssigbrodt; Silke John; Jedrzej Kosiuk; Sergio Richter; Gerhard Hindricks; Andreas Bollmann
Journal:  Europace       Date:  2015-06-07       Impact factor: 5.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.